Hydrochloric Acid

Hydrochloric Acid

SCHEMBL587795

CCC[N+](CCC)(CCC)CC1CO1.[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 11/20 0.38
CHRM3 known ✓ P20309 7/20 0.38
CHRM1 known ✓ P11229 4/20 0.34
SLC22A1 O15245 1/20 0.41
ALDH1A1 P00352 3/20 0.38
CHRM5 P08912 8/20 0.38
CHRM4 P08173 5/20 0.38
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
PRKD3 O94806 2/20 0.33
PRKCG P05129 2/20 0.33
PRKCB P05771 2/20 0.33
PRKCA P17252 2/20 0.33
PRKCH P24723 2/20 0.33
PRKCI P41743 2/20 0.33
PRKCE Q02156 2/20 0.33
PRKCQ Q04759 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5196667 0.98 SLC22A1 (0.43) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
Iodide SCHEMBL10704645 0.95 CHRM2 (0.42) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
Bromide SCHEMBL18260613 0.95 SLC22A1 (0.41) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
Hydrochloric Acid SCHEMBL7943589 0.91 SLC22A1 (0.38) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
Hydrochloric Acid SCHEMBL2186924 0.88 ALDH1A1 (0.48) SLC22A1ALDH1A1TSHRSMN1; SMN2PRKD3
Hydrochloric Acid SCHEMBL9636325 0.86 SLC22A1 (0.46) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
Hydrochloric Acid SCHEMBL10343542 0.85 SLC22A1 (0.50) SLC22A1ALDH1A1TSHRSMN1; SMN2PRKD3
Bromide SCHEMBL15210680 0.84 ALDH1A1 (0.52) SLC22A1ALDH1A1TSHRSMN1; SMN2PRKD3
SCHEMBL11125716 0.84 SLC22A1 (0.48) SLC22A1ALDH1A1CHRM2CHRM5CHRM3
SCHEMBL18260612 0.81 CHRM2 (0.33) SLC22A1CHRM2CHRM5CHRM3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119081107-B Water-soluble high-cation charge density active compound and preparation method and application thereof 华南理工大学 2026-05-19 CN claimed
US-20250388705-A1 WATER-SOLUBLE, BIODEGRADABLE DIHYDROXYALKYL CELLULOSE ISP INVESTMENTS LLC (US) 2025-12-25 US claimed
EP-4581094-A2 WATER-SOLUBLE, PARTIALLY BIODEGRADABLE DIHYDROXYALKYL CELLULOSE ISP Investments LLC (US) 2025-07-09 EP claimed
CN-119998333-A Water-soluble, partially biodegradable dihydroxyalkyl cellulose 埃斯普投资有限公司 2025-05-13 CN claimed
CN-119081107-A Water-soluble high-cation charge density active compound and preparation method and application thereof 华南理工大学 2024-12-06 CN claimed
CN-113929817-B Modified chitosan high-temperature-resistant salt-resistant filtrate reducer, and preparation method and application thereof 中石化石油工程技术服务有限公司 2024-05-17 CN claimed
CN-116535540-B Quaternized modified chitin, sponge thereof, preparation method of porous microsphere and application of quaternized modified chitin 武汉大学 2024-04-12 CN claimed
WO-2024049833-A2 WATER-SOLUBLE, PARTIALLY BIODEGRADABLE DIHYDROXYALKYL CELLULOSE ISP INVESTMENTS LLC (US) 2024-03-07 WO claimed
CN-117488424-A Grafted long-acting antibacterial toothbrush and preparation method thereof 抚州市金灿医疗科技有限公司 2024-02-02 CN claimed
CN-116535540-A Quaternized modified chitin, sponge thereof, preparation method of porous microsphere and application of quaternized modified chitin 武汉大学 2023-08-04 CN claimed
CN-102585109-B Styrene-acrylic emulsion and preparation method thereof GUANGZHOU STARTEC SCIENCE & TECHNOLOGY CO LTD 2013-12-18 CN claimed
CN-101035811-B Reduced odor in low molecular weight cationic polygalactomannan HERCULES INC 2012-10-31 CN claimed
CN-102585109-A Styrene-acrylic emulsion and preparation method thereof GUANGZHOU STAR TECHNOLOGY CO LTD 2012-07-18 CN claimed
EP-1791871-B1 PROCESS FOR PREPARING REDUCED ODOR LOW MOLECULAR WEIGHT CATIONIC POLYGALACTOMANNAN HERCULES INC (US) 2012-02-15 EP claimed
US-20090281056-A1 Cationized Hyaluronic Acid SHISEIDO CO., LTD. (JP) 2009-11-12 US claimed
CN-101035811-A Reduced odor in low molecular weight cationic polygalactomannan HERCULES INC (US) 2007-09-12 CN claimed
CN-101027038-A High DS cationic polygalactomannan for skincare products HERCULES INC (US) 2007-08-29 CN claimed
CN-101010343-A Functional system of cationic polygalactomannan with reduced odor HERCULES INC (US) 2007-08-01 CN claimed
EP-1501873-B1 A CATIONIC POLYMER COMPOSITION AND ITS USE IN CONDITIONING APPLICATIONS HERCULES INC (US) 2007-05-30 EP claimed
CN-1780857-A Cationic,oxidized polysaccharides in conditioning applications HERCULES INC (US) 2006-05-31 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388705-A1 WATER-SOLUBLE, BIODEGRADABLE DIHYDROXYALKYL CELLULOSE IDUA, ALG1, MGAM CHRM2 2155/4885CHRM3 2467/4885CHRM1 2428/4885
US-20090281056-A1 Cationized Hyaluronic Acid CD44, GYPA, HYPK CHRM2 3088/4885CHRM3 2352/4885CHRM1 2781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.